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326Objective: This study was to determine whether atrioventricular valve repair modifies natural history of
single-ventricle patients with atrioventricular valve insufficiency and to identify factors predicting survival
and reintervention.
Methods: Fifty-seven (13.5%) of 422 single-ventricle patients underwent atrioventricular valve repair. Valve
morphology, regurgitation mechanism, and ventricular morphology and function were analyzed for effect on
survival, transplant, and reintervention with multivariate logistic and Cox regression models. Comparative
analysis used case-matched controls.
Results:Atrioventricular valvewas tricuspid in 67% and common in 28%. Ventricular morphology was right in
83%. Regurgitation mechanisms were prolapse (n ¼ 24, 46%), dysplasia (n ¼ 18, 35%), annular dilatation
(n ¼ 8, 15%), and restriction or cleft (n ¼ 2, 4%). Postrepair insufficiency was none or trivial in 14 (26%),
mild in 33 (61%), and moderate in 7 (13%). Survival in repair group was lower than in matched controls
(78.9% vs 92.7% at 1 year, 68.7% vs 90.6% at 3 years, P ¼ .015). Patients with successful repair and normal
ventricular function had equivalent survival to matched controls (P ¼ .36). Independent predictors for death or
transplant included increased indexed annular size (P¼ .05), increased cardiopulmonary bypass time (P¼ .04),
and decreased postrepair ventricular function (P ¼ .01). Ventricular dilation was a time-related factor for all
events, including failed repair.
Conclusions: Survival was lower in single-ventricle patients operated on for atrioventricular valve insufficiency
than in case-matched controls. Patients with little postoperative residual regurgitation and preserved ventricular
function had equivalent survival to controls. Lower grade ventricular function and ventricular dilation correlated
with death and repair failure, suggesting that timing of intervention may affect outcome. (J Thorac Cardiovasc
Surg 2011;142:326-35)Supplemental material is available online.
Significant atrioventricular valve (AV) insufficiency in
single-ventricle physiologywas one of the contraindications
for staged single-ventricle palliation in the past.1 Introduc-
tion of various AV repair techniques2,3 and application of
AV repair during the staged palliation made Fontan
completion among those patients feasible. Nevertheless,
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The Journal of Thoracic and Cardiovascular Surghigher risk,4,5 AV insufficiency is still associated with
failure of the cavopulmonary circulation.2,6,7
Mechanisms of AV insufficiency in a single-ventricle
physiology are complex and multifactorial.8,9 Chronic
volume overload with a physiology dependent on systemic-
to-pulmonary shunt causes progressiveventricular dilatation.
Subsequent annular dilatation may cause central malcoapta-
tion, leading toAVinsufficiency. AV leaflets and the subvalv-
ular apparatus in functionally univentricular hearts are often
abnormal.10 A tricuspid valve as the systemic AVappears to
bemore prone to functional tricuspid valve insufficiency than
does a mitral valve. Reduced ventricular function is also as-
sociated with the development of AV insufficiency.
We hypothesized that ventricular function, AV mor-
phology, and mechanism of insufficiency all play impor-
tant roles in determining patient outcome. In this study
we attempted to answer 2 questions: (1) What is the rela-
tionship between ventricular function and success or fail-
ure of AV repair? (2) Does AV repair modify the natural
history of the single-ventricle patients with significant
AV insufficiency? Cohort and case–control analyses
were performed.ery c August 2011
Abbreviations and Acronyms
AV ¼ atrioventricular valve
BCPS ¼ bidirectional cavopulmonary shunt
BSA ¼ body surface area
CPB ¼ cardiopulmonary bypass
TEE ¼ transesophageal echocardiography
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We reviewed the cases of all patients who underwent staged single-
ventricle palliation between January 1998 and December 2008 at The
Hospital for Sick Children, Toronto, Ontario, Canada. The institution’s re-
search ethics board approved the study and waived the requirement for pa-
tient consent. Of the 442 patients who underwent single-ventricle
palliation, 57 (13.5%) also underwent AV repair. Diagnoses and preoper-
ative characteristics are shown in Table E1. AV morphologies, types of
AV abnormalities, and ventricular function grades are shown in Table 1.
Threshold and Timing of AV Repair
Moderate or greater AV insufficiency was our clear indication for adding
AVrepair to analreadyplanned stagedoperation.We inspected andattempted
to repair AVs with mild to moderate insufficiency because we believe that
those AVs are often structurally abnormal. Details of the timing of repair in
this case series are outlined in Table E1. Wewere hesitant to perform a com-
plex AV repair at the stage III procedure and instead tended to perform a sep-
arate procedure for AV repair in cases of severe interstage II and III AV
regurgitation. Our preferred time for repair was at the time of the stage II bi-
directional cavopulmonary shunt (BCPS). Valve repair in a neonate was rare
in this case series. Someneonateswith single-ventricle physiology and severe
AV insufficiency were instead assigned to undergo primary heart transplant.
Surgical Techniques
Standard cardiopulmonary bypass (CPB) was established, with mild to
moderate hypothermia. Deep hypothermic circulatory arrest was used only
when performing other concomitant procedures, such as aortic arch recon-
struction and pulmonary vein repair. An initial saline injection test deter-
mined the mechanism of AV insufficiency. Special attention was paid to
the annular dimension, commissural leak, prolapse or restriction of the
leaflets, and leaflet and subvalvular abnormalities. Local annuloplasty
and commissuroplasty were the 2 main techniques used for annular
dilatation, leaflet prolapse, or both. We typically used 5-0 polypropylene
horizontal mattress sutures to reduce the annular size along the commis-
sures where the regurgitant jet mainly arose. The maneuver could serve
as a functional commissuroplasty on the corresponding commissure.
Anatomic commissuroplasty was achieved with 6-0 or 7-0 polypropylene
simple sutures placed on the leaflet tissue as an edge-to-edge approxima-
tion, such as one would use to close a cleft. We occasionally obliterated
the posterior leaflet of the tricuspid valve, as described by Bove and col-
leagues.8,11 An artificial annuloplasty ring was only used in patients with
an adult-sized annulus. Neither a semicircular nor a circular annuloplasty
was used in our series. A localized or generalized prolapse with essentially
normal chordae and subvalvular apparatus on the adjacent leaflet was
treated with an edge-to-edge commissure approximation12 to attach the
prolapsed region to the nonprolapsed region. A local annuloplasty was
usually added. Clefts were primarily closed with interrupted polypropylene
sutures. Nodular dysplastic leaflet edges were made as smooth as possible
by the attachment of the nodules to each other. Dysmorphic leaflets with
serpiginous edges were treated in a similar manner to improve the linearity
of the coaptation area. The definition of AV dysplasia used was myxoid
thickening, nodular irregularity of the leaflet edge, or both, whereas dys-The Journal of Thoracic and Camorphic leaflet was considered to be the presence of 1 or more relatively
large gaps or accessory commissures of the leaflet, resulting in malcoapta-
tion or localized prolapse. Intraoperative transesophageal echocardiogra-
phy (TEE) was routinely performed, and any less than moderate residual
AV insufficiency found on TEE was acceptable. Our intent was to revise
the repair in cases of moderate or greater residual regurgitation. Replace-
ment of an AV was performed in cases of greater than moderate residual
regurgitation or if surgical inspection showed irreparable leaflet abnormal-
ities. A standard bileaflet mechanical valve was used.
Echocardiographic Evaluation
Original echocardiographic images were evaluated by an echocardio-
graphic investigator (L.M.) who was blinded to the original echocardio-
graphic report and to clinical outcome. Morphologies of the AVs and
ventricles were determined. Structural abnormalities of the AVs, including
annular dilatation, cleft, prolapse, chordal elongation or deficiency,
restriction, dysplasia, and papillary muscle abnormalities, were assessed
(Table 1). Both primary and secondary mechanisms of AV insufficiency
were determined. The AV insufficiency, stenosis, and ventricular function
grades we used are listed in Table E2. Ventricular dimension and AVannu-
lar dimension were measured from the apical 4-chamber view and were
indexed by body surface area (BSA) as millimeters per square meter.
Case-Control Study
Three control patients were matched to each study patient on the basis of
diagnosis, body weight, BSA, ventricular and AV morphologies, and type,
number, and timing of the staged palliations. Body weight and BSAwere
matched at prerepair measurement. A single best fit was then chosen
according to ventricular function and AV insufficiency grades and verified
by actual echocardiographic imaging review. In terms of ventricular
function, an equivalent grade or a single grade difference was accepted.
Freedom from death or transplant and freedom from all events were com-
pared between the matched control group and the valve repair group.
Outcome Assessment
FailedAV repair was defined as evidence ofmore thanmoderate residual
AVinsufficiency on intraoperative TEE. In-hospital death was defined as all
deaths that occurred after the AV repair and within 30 days or the same hos-
pitalization. Two composite outcomes—freedom form death or transplant
and freedom from all events, including death, transplant, repeated repair,
or replacement—were defined. These outcomes were compared with re-
spect to the diagnosis, ventricular and AV morphologies, primary mecha-
nism, and timing of surgery. The cohort was separated into 4 subgroups
according to postrepair AV and ventricular functions (Table E2). The
outcomes were then compared among these 4 groups. The predictors for
repeated repair or replacement were analyzed among the patients who
survived without transplant longer than 6 months after the initial AV repair.
Statistical Analysis
Data are presented as mean  SD. Differences between the study
patients and the control patients were analyzed with a paired t test or
a Wilcoxon signed rank test. Frequencies of the events were compared
between the groups with a c2 test. Correlations between preoperative
and postoperative values were analyzed with the Pearson correlation
coefficient. Differences in ventricular function grades over time were an-
alyzed with 1-way analysis of variance. Freedom from death or transplant
and freedom from all events (death, transplant, repeated repair, or re-
placement) were analyzed with Kaplan-Meier survival analysis, with
a log-rank test used for comparisons between the groups. Multivariate lo-
gistic regression of the entire cohort was used to determine independent
variables of risk for the end points of freedom from death or transplant
and freedom from all events (death, transplant, repeated repair, or re-
placement). Cox regression models were used to determine the time-
related predictors for the outcomes.rdiovascular Surgery c Volume 142, Number 2 327
TABLE 1. Echocardiographic findings: Atrioventricular valve
morphology, insufficiency, and ventricular function
Variables RV LV Indeterminate Total
Valve morphology
Mitral valve 0 2 0 2 (4%)
Tricuspid valve 38 0 0 38 (67%)
Common AV 9 6 1 16 (28%)
Indeterminate 0 0 1 1 (2%)
AV insufficiency
Mild to moderate 4 1 1 6 (11%)
Moderate 31 5 1 37 (65%)
Severe 12 2 0 14 (25%)
Valve abnormalities
Annular dilatation 35 5 1 41 (77%)
Cleft 7 3 1 11 (21%)
Prolapse 24 2 1 27 (51%)
Chordal elongation 21 1 0 22 (42%)
Restriction 24 2 0 26 (49%)
Dysplasia 21 5 1 27 (52%)
Papillary muscle abnormality 4 0 0 4 (8%)
Primary mechanism
Annular dilatation 8 0 0 8 (15%)
Prolapse 22 2 0 24 (46%)
Restriction 1 0 0 1 (2%)
Dysplasia 12 5 1 18 (35%)
Cleft 1 0 0 1 (2%)
Secondary mechanism
Annular dilatation 11 2 0 13 (25%)
Prolapse 3 0 1 4 (8%)
Restriction 4 0 0 4 (8%)
Dysplasia 5 0 0 5 (10%)
Cleft 21 5 0 26 (50%)
Ventricular function
Normal 27 6 1 34 (64%)
Mildly reduced 14 1 0 15 (28%)
Moderately reduced 3 0 0 3 (6%)
Severely reduced 1 0 0 1 (2%)
Ventricular dilatation
Normal 0 1 1 2 (4%)
Mildly dilated 1 0 0 1 (2%)
Moderately dilated 35 6 0 41 (77%)
Severely dilated 9 0 0 9 (11%)
Data represent numbers of patients. RV, Right ventricle; LV, left ventricle; AV, atrio-
ventricular valve.
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DRESULTS
Hypoplastic left heart syndrome and unbalanced atrio-
ventricular defect accounted for 59% and 19% of cases, re-
spectively (Table E1). The right ventricle was the dominant
ventricle in 83% of cases. More than half the patients
(59%) underwent AV repair at stage II palliation. Ten
(17%) patients underwent AV repair as a stand-alone proce-
dure between stage II and stage III operations.
There were 3 patients with a single-ventricle physiology
who were listed for primary transplant, primarily as a result
of significant AV insufficiency in the study period.328 The Journal of Thoracic and Cardiovascular SurgAV Morphology and Mechanism of Insufficiency
The most common AV type was tricuspid valve (67%),
followed by common AV (28%). Mitral valve morphology
was seen in 2 patients (4%). Preoperative AV insufficiency,
ventricular function and dilatation, and types of AV abnor-
malities are shown in Table 1. The most common primary
mechanism was prolapse (n ¼ 24, 46%), followed by dys-
plasia (n¼ 18, 35%). Pure annular dilatation accounted for
15% (n¼ 8) of cases. Twenty six patients (57%) had 2 ma-
jor mechanisms of AV insufficiency. A cleft was the most
common secondary mechanism for AV insufficiency
(50%). Preoperative ventricular function was mildly re-
duced in 15 patients (28%) and moderately or severely
reduced in 4 patients (8%).Immediate Outcomes of AV Repair
More than 1 technique was used for most patients, with
annuloplasty being the most common (85%), followed
by commissuroplasty (54%) and cleft closure (33%;
Table E3). Three (4%) patients underwent artificial ring an-
nuloplasty. Postrepair AV insufficiency was none or trivial
in 14 patients (26%), mild in 33 patients (61%), and mod-
erate in 7 patients (13%). Valve insufficiency gradewas sig-
nificantly reduced with repair (prerepair 2.1  0.57 vs
postrepair 0.84  0.62, P ¼ .0001; Figure E1). Postrepair
AV stenosis was mild in 9 patients (15%) and moderate
in 1 patient (2%). Postrepair ventricular function was nor-
mal in 36 patients (63%), mildly reduced in 10 patients
(17%), moderately reduced in 7 patients (13%), and se-
verely reduced in 4 patients (7%).Independent Predictors of Poor Valve and
Ventricular Function
Preoperative ventricular dilatation was a predictor for
a failed repair (more than moderate residual AV insuffi-
ciency, P ¼ .03). The predictors for moderately or severely
reduced ventricular function as seen on TEE included deep
hypothermic circulatory arrest (P¼ .03) and annular dilata-
tion as the primary mechanism of insufficiency (P ¼ .04).
Prerepair ventricular function was correlated with postre-
pair ventricular function (r¼ .569, P¼ .01) but did not pre-
dict postrepair ventricular dysfunction (difference not
significant). Preoperative ventricular dilatation was weakly
positively correlated with postoperative ventricular func-
tion (r ¼ .3, P ¼ .04). Six of 8 patients who had annular di-
latation as the primary mechanism (75%) had postrepair
ventricular dysfunction.Survival
There were 8 in-hospital deaths (14%; Table E4). Two
patients who had moderate residual AV insufficiency died,
1 of sudden cardiac arrest and the other of progressive ven-
tricular failure. There were 3 early deaths of patients withery c August 2011
FIGURE 1. Kaplan-Meier survival analyses of the single-ventricle patients undergoing atrioventricular (AV) valve repair. Cumulative (Cum) survivals are
given by diagnosis (A), by ventricular morphology (B), by atrioventricular valve morphology (C), and among 4 subgroups determined according to
postrepair residual atrioventricular valve insufficiency and ventricular function (D). AVSD, Atrioventricular septal defect; HLHS, hypoplastic left heart
syndrome; TA/DILV, tricuspid atresia with double-inlet left ventricle; DORV, double-outlet right ventricle; LV, left ventricle; RV, right ventricle.
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stage I palliation and underwent early stage II palliation
with AV repair. There were 9 late deaths (15%), including
3 cardiac-related deaths.
No differences were found in survival among diagnoses
(P ¼ .8), ventricular (P ¼ .4) or AV morphology (P ¼ .8),
mechanism of insufficiency (P ¼ .16), or timing of surgery
(P ¼ .4; (Figure 1, A, B, and C). The survival according to
postrepair ventricular function and AVinsufficiency divided
into groups showed the group who had successful repair
with normal ventricular function to have significantly better
survival than other groups (P ¼ .02; Figure 1, D).
Risk Factor Analysis
Independent predictors for death or transplant included
increased indexed AV annular size (P ¼ .05), increased
CPB time (P ¼ .04), and decreased postrepair ventricularThe Journal of Thoracic and Cafunction (P ¼ .01). The predictors for all events were in-
creased indexed AV annular (P ¼ .006) and ventricular
(P ¼ .02) dimensions, increased aortic crossclamp
(P ¼ .01) and CPB (P ¼ .002) times, and decreased postre-
pair ventricular function (P ¼ .02). Failed repair did not
reach statistical significance (P¼ .07) as a predictor. Repair
era was not identified as a predictor for survival (difference
not significant).
Cox regression showed that predictors for death or trans-
plant included CPB time (P ¼ .02), annular dilatation as
a primary mechanism (P¼ .02), postrepair AV insufficiency
grade (P ¼ .03), and postrepair ventricular function
(P ¼ .02). Predictors for all events (death, transplant, and
reoperation) included BSA (P ¼ .008), CPB time
(P ¼ .001), and preoperative ventricular dilatation
(P¼ .05). None of the preoperative anatomic characteristics
were shown to be predictors for death or transplant.rdiovascular Surgery c Volume 142, Number 2 329
FIGURE 2. A, Competing risk outcomes for the entire cohort. B, The flow chart for the 57 patients who underwent atrioventricular (AV) valve repair.
SV, Single ventricle.
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DA competing risk outcome of the entire cohort is shown in
Figure 2, A.Repeated Repair or Replacement
Ten patients (17%) required repeated repair or replace-
ment at a median of 21 months (mean, 22 months; range,
2–62 months) after the AV repair (Figure 2, B). The mech-
anisms of recurrent AV insufficiency were as follows: recur-
rent annular dilatation (n ¼ 3), dysplasia and annular
dilatation (n ¼ 4), cleft (n ¼ 2), and double orifice and an-
nular dilatation (n¼ 1). Four patients with severely dysplas-
tic leaflets required mechanical valve replacement. Among
these 10 patients, prerepair ventricular function was normal
in 8 patients, mildly reduced in 1 patient, and moderately re-
duced in 1 patient. Among the 6 patients who underwent
a second AV repair, residual AV insufficiency grade was
none or trivial in 1 patient, mild in 4 patients, and mild to
moderate in 1 patient. Four patients had mild AV stenosis
after the operation. The overall survival was 70% at both
1 and 3 years (causes of deaths listed in Table E4). There
was no difference in survival between the repeated repair
group and the replacement group (P ¼ .6). One patient
who underwent repeated repair had a successful valve
replacement 23 months later.Independent Risks for Repeated Repair or
Replacement
Among the early survivors (survival without transplant
more than 6 months after AV repair, n ¼ 49), younger age
at repair (P ¼ .05), smaller BSA (P ¼ .03), increased
indexed AV annular (P ¼ .002) and ventricular (P ¼ .01)
dimensions, leaflet dysplasia (P ¼ .03), and residual AV
insufficiency (P ¼ .05) were the significant risk factors330 The Journal of Thoracic and Cardiovascular Surgfor reintervention. Initial diagnosis, ventricular or AV mor-
phology, mechanism of insufficiency, and timing of surgery
were not found to be predictors for reintervention (differ-
ence not significant for all).Follow-up
The median follow-up period was 59 months (mean 52
months, range 1–128 months). The statuses among the 41
long-term survivors are shown in Figure 2, B. The latest
echocardiographs of the 34 survivors who as of most recent
follow-up still had a single-ventricle physiology with a na-
tive AV showed that AV insufficiency was none or trivial in
6 patients (17%), mild in 23 patients (67%), and moderate
in 5 patients (14%). There was mild AV stenosis in 3 pa-
tients (8%). Ventricular function was normal in 29 patients
(85%), mildly reduced in 4 patients (11%), and moderately
reduced in 1 patient (8%). Among 22 patients who had
some postrepair ventricular dysfunction, ventricular func-
tion was improved in 7 patients (32%), unchanged in 10
patients (45%), and further reduced in 5 patients (23%)
at 1 month after AV repair. There was no statistical differ-
ence in ventricular function grade over 5 years (P ¼ .12).Case-Control Outcomes
Seven patients (12%) were excluded from the case–con-
trol study because of lack of a matched patient. The remain-
ing 50 patients had complete matching in diagnosis, age,
body weight, BSA, and types and timing of palliation
according to the criteria. Of the 50 patients, 44 (84%)
completely met match criteria. Six had more than 1 grade
difference in ventricular function. The comparison of
preoperative and postoperative variables between the
groups is shown in Table 2.ery c August 2011
TABLE 2. Patient characteristics in the case–control study
Variables Valve repair Control P value
Age (mo, median and range) 6 (0–127) 6 (0-169) .56
Body weight (kg, median and range) 5.98 (2.1–32) 6 (2-32) .39
Male/female ratio 28:21 35:14
Diagnosis (no.)
Hypoplastic left heart syndrome 32 (59%) 28 (57%)
Double-outlet right ventricle 8 (15%) 7 (14%)
Atrioventricular septal defect 10 (19%) 5 (10%)
Tricuspid atresia and double-inlet left ventricle 4 (7%) 3 (6%)
Isomerism 5 (9%) 2 (4%)
Indeterminate 0 (0%) 4 (8%)
Ventricular morphology (no.)
Right ventricle 48 (84%) 43 (88%)
Left ventricle 7 (12%) 6 (12%)
Indeterminate 2 (4%) 0 (0%)
Preoperative AV regurgitation grade (mean  SD) 2.1  0.57 0.77  0.56 .0001
Preoperative ventricular function grade (mean  SD) 0.45  0.69 0.22  0.55 .07
In-hospital death (no.) 8 (14%) 2 (3.5%) .5
Cardiopulmonary bypass (min, median and range) 118 (50–405) 94 (8-272) .005
Aortic crossclamp (min, median and range) 60 (15–178) 45.4 (14-155) .74
Circulatory arrest 15 (25%) 10 (20.4%) .05
Postoperative AV regurgitation grade 0.84  0.62 0.61  0.57 .12
Postoperative ventricular function grade 0.70  0.95 0.28  0.64 .01
AV, Atrioventricular valve.
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DFreedom from death or transplant was significantly lower
in the valve repair group than in the matched control group
(78.9% vs 92.7% at 1 year, 68.7% vs 90.6% at 3 years,
P ¼ .015; Figure 3, A). Freedom from all events (death,
transplant, repeated repair or replacement) was also signif-
icantly lower in the valve repair group than in the matched
control group (78.8% vs 92.8% at 1 year, 58.4% vs 92.7%
at 3 years, P¼ .01). The subgroup analysis, which was per-
formed on the 4 groups determined by postrepair AV insuf-
ficiency and ventricular function, showed that group 1
(successful repair with normal ventricular function) had
equivalent freedoms both from death or transplant and
from all events to the control group (death or transplant
82.7% vs 89.6% at 1 year, 76.1% vs 79.6% at 3 years,
P ¼ .36, all events 82.7% vs 92.4% at 1 year, 66.9% vs
81.4% at 3 years, P ¼ .19; Figure 3, B). In group 2 (poor
repair with normal ventricular function), both freedom
from death or transplant and freedom from all events
were significantly lower in the valve repair group than in
the control group (P ¼ .03). The numbers of patients in
groups 3 and 4 were not sufficient for statistical analysis.DISCUSSION
Valve repair resulted in measurably improved valve
function regardless of the anatomic lesion. Most of the
AV insufficiency (85%) was related to anatomic abnormal-
ities of the leaflets or subvalvular apparatus. Among the
remaining patients who had pure annular dilation (15%),The Journal of Thoracic and Cathere was a strong correlation with postrepair ventricular
dysfunction and attendant poor survival. Overall survival
was significantly worse than that of the case-matched con-
trol group, despite early attempts to eliminate insufficiency.
Subgroup analysis showed that patients with successful re-
pair and preserved ventricular function (74% of the entire
cohort) had equivalent early and midterm survivals.Factors Associated With Death or Transplant
Our analysis showed preoperative severe annular dilata-
tion (which is highly correlated with ventricular dilatation,
r ¼ .75, P ¼ .0001), CPB time, residual AV insufficiency,
and postrepair ventricular function to be predictors for
death or transplant. Preoperative morphologic and func-
tional characteristics were unrelated to survival.
Preoperative ventricular dilatation was found to be
among the predictors both for failed repair and for all events
(death, transplant, reintervention). Preoperative ventricular
dilatation grade was also correlated with the postrepair
ventricular function (r ¼ .3, P ¼ .04). This phenomenon
is common among adult patients undergoing mitral valve
repair, in whom the preoperative ventricular dimension
predicts postoperative ventricular dysfunction.13
The data suggest that in those with AV insufficiency,
successful valve intervention for signs of progressive
ventricular dilatation could prevent irreversible changes in
ventricular geometry and subsequent function impairment.
Practically speaking, the use of relatively simple repairrdiovascular Surgery c Volume 142, Number 2 331
FIGURE 3. Kaplan-Meier survival analysis comparing cumulative (Cum) survivals between the valve repair group and a case-matched control group.
A, Entire cohort (n¼ 56). B, The subgroup of the valve repair groupwith successful repair with normal ventricular function (group 1, n¼ 41) and its matched
control group.
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might be beneficial.
Relationship Between Ventricular Function and AV
Insufficiency
This study showed a strong relationship between postre-
pair ventricular function and death or transplant. Twelve of
the 15 patients who had moderately or severely reduced
ventricular function on postrepair TEE (75%) eventually
reached the end point of mortality or transplant. Chronic
volume-related ventricular dysfunction may or may not be
reversible by AV repair.14 Progressive postrepair ventricular
dysfunction may cause redilatation of the AV annulus.8
Ohye and associates8,11 showed that the patients with
early and late success of tricuspid valve repair tended to
have preserved function and simple repair.
Factors Associated With Repeated Repair or
Replacement
The multivariate logistic regression identified small
patients (by age and BSA), dilated annulus and ventricle,
leaflet dysplasia, and residual AVinsufficiency as predictors
for repeated repair or replacement among the early survi-
vors. Furthermore, all 4 patients who had dysplasia as
the primary mechanism of reintervention underwent AV re-
placement at the second repair. The results indicate that sig-
nificant residual AV insufficiency associated with dysplastic
valve may necessitate subsequent valve replacement. Other
ventricular and AV morphologies were not associated with
reintervention.332 The Journal of Thoracic and Cardiovascular SurgDurability of Repeated Repair or Replacement for
Current AV Insufficiency
Mahle and colleages15 reported the cases of 17 patients
who underwent AV replacement. Ten of these 17 patients
(59%) had previously undergone AV repair. Ohye and asso-
ciates8,11 reported their experiences with repeated repair for
residual or recurrent tricuspid valve insufficiency in patients
with hypoplastic left heart syndrome. Most of the patients
who had failure of the repair had ventricular dysfunction.
Subsequent survival of the subgroup was 25%. Our series
showed a survival of 70% at both 1 year and 3 years;
however, most had preserved ventricular function.
Timing of AV Repair: Rationale for Early
Intervention
Approximately two thirds of the patients underwent AV
repair along with the BCPS. The decision to intervene at
stage II for mild to moderate or greater insufficiency has
the potential to prevent volume overload related to the
regurgitation. The risk of ventricular geometric changes
and functional deterioration may be minimized. Mahle
and coworkers16 suggested a different approach in which
they left most patients with moderate or severe AV insuffi-
ciency untreated at stage II palliation. Repair was later per-
formed if necessary. They showed equivalent short-term
survival between patients with and without significant AV
insufficiency.
For those patients who have significant insufficiency after
the BCPS, our strategy is to perform the repair as a stand-
alone procedure if the patient has symptoms. We haveery c August 2011
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Doccasionally combined repair with the Fontan operation,
but only if this can be performed simply and efficiently.
Fontan physiology results in significant reduction in total
cardiac output.2,17 Our thinking is that a combination of
potential for reduced ventricular function, a lengthy
procedure for AV repair, and the subsequent significant
physiologic changes of the Fontan circulation may not be
well tolerated.
Effect of Volume Unloading Surgery on AV
Insufficiency
Functional AV insufficiency resulting from chronic vol-
ume overload can theoretically be improved by eliminating
left-to-right shunt physiology and converting to an in-series
circulation of a BCPS at stage II palliation.16,18 There is
some evidence that a BCPS results in a decrease in the
ventricular volume19 or the annular dimension20; however,
previous clinical series showed no or minimal improve-
ment in moderate to severe AV insufficiency after
BCPS.3,16 Mahle and coworkers16 showed that only 6 of
36 patients who had moderate or severe AV insufficiency
at the time of BCPS (22%) had improved AV insufficiency
grade without AV repair. Ten patients (37%) subsequently
required AV repair. Their findings of need for later repair
and minimal improvement by unloading are congruent
with our data showing a high incidence of anatomic
abnormalities associated with regurgitation. With respect
to volume unloading in stage II, recent magnetic resonance
imaging data measuring the net left-to-right shunt after
a BCPS demonstrate a pulmonary/systemic flow ratio close
to 1:1 as a result of the development of chest wall collat-
erals.21 The volume unloading of a BCPS therefore appears
to be temporary.
Study Limitation
An ideal matching group would consist of patients with
a case match of ventricular function grade and AV insuffi-
ciency. Because our policy is to intervene for mild to mod-
erate or greater insufficiency, it was not possible to match
for equivalent insufficiency. Therefore this study does not
have direct data on the natural history of the patients with
mild to moderate or moderate AV insufficiency without
AV repair, and positive or negative effects of the early
AV repair strategy for this particular subgroup can
only be inferred from a multivariate analysis. Magnetic
resonance imaging data would allow a more accurate
assessment of indices of systolic function and ventricular
dilatation.
CONCLUSIONS
Most (85%) of the AV insufficiency in patients with
a functionally univentricular heart was related to ana-
tomic abnormalities. Repair measurably improved the
grade of insufficiency. Successful repair with preservedThe Journal of Thoracic and Capostrepair ventricular function was related to a survival
equivalent to that of a matched control group. Valve repair
for functional AV insufficiency, which was frequently
related to ventricular dysfunction, was not beneficial.
Preoperative ventricular dilatation, pure annular dilata-
tion, and postrepair ventricular and valve dysfunction
were independent predictors of poor survival or composite
outcomes, which suggests that strategies designed to pre-
vent progressive ventricular dilatation and remodeling
and to preserve ventricular and valve function would
affect clinical outcomes.References
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MRI. Circ Cardiovasc Imaging. 2009;2:219-25.APPENDIX. Variables for Risk Factor Analysis
1. Age (months)
2. Sex
3. Body weight at surgery (kilograms)
4. Body surface area (square meters)
5. Diagnosis
6. Isomerism
7. Hypoplastic left heart syndrome
8. Previous Norwood procedure
9. Timing of surgery
10. Ventricular morphology (left, right, indeterminate)
11. Atrioventricular valve morphology
12. Prerepair atrioventricular valve regurgitation grade
13. Atrioventricular valve annulus size (millimeters)
14. Indexed atrioventricular valve annulus size (millime-
ters per square meter)
15. Affected leaflet: anterior, posterior, septal, mural or
lateral, other
16. Regurgitation mechanism: annular dilatation (yes/no)
17. Regurgitation mechanism: cleft (yes/no)
18. Regurgitation mechanism: prolapse (yes/no)
19. Regurgitation mechanism: chordal elongation (yes/no)
20. Regurgitation mechanism: chordal deficiency (yes/no)
21. Regurgitation mechanism: leaflet restriction (yes/no)
22. Regurgitation mechanism: leaflet thickening (yes/no)
23. Regurgitation mechanism: dysplasia (yes/no)
24. Regurgitation mechanism: papillary muscle abnormal-
ities (yes/no)
25. Regurgitation mechanism: endocardial fibroelastosis
(yes/no)
26. Pre repair ventricular function (grade 0–3)
27. Pre repair ventricular dilatation (grade 0–3)
28. Primary mechanism of atrioventricular valve regurgita-
tion
29. Secondary mechanism of atrioventricular valve regur-
gitation
30. Ventricular dimension (millimeters)
31. Indexed ventricular dimension (millimeters per square
meter)
32. Surgical technique: annuloplasty
33. Surgical technique: commissuroplasty
34. Surgical technique: valvuloplasty
35. Surgical technique: chordal repair
36. Surgical technique: cleft closure334 The Journal of Thoracic and Cardiovascular Surg37. Surgical technique: edge-to-edge repair
38. Papillary muscle repair
39. Aortic crossclamp time (minutes)
40. Cardiopulmonary bypass time (minutes)
41. Deep hypothermic circulatory arrest (yes/no)
42. Deep hypothermic circulatory arrest time (minutes)
43. Intraoperative transesophageal echocardiogram: resid-
ual atrioventricular valve regurgitation (grade 0–3)
44. Intraoperative transesophageal echocardiogram: residual
atrioventricular valve stenosis (grade 0–3)
45. Intraoperative transesophageal echocardiogram: ven-
tricular function (grade 0–3)Discussion
Dr Jennifer C. Hirsch (Ann Arbor, Mich). Congratulations on
a nicely presented article. I am pleased to have the opportunity to
discuss this excellent presentation by Dr Honjo and colleagues at
The Hospital for Sick Children in Toronto.
As mentioned, the progression of AV regurgitation in a single-
ventricle population poses a significant challenge regarding
surgical options, timing of intervention, and long-term prognosis.
With limited donor availability, every attempt to remediate ven-
tricular and atrioventricular function in the native heart is the ideal
objective.
Dr Honjo, you have presented excellent outcomes for patients in
whom successful repair has been accomplished. The incorporation
of the case–control study provides a valuable attempt to bench-
mark the outcomes against those of the overall single-ventricle
population. Your presentation, as well as the manuscript that you
submitted earlier, is thought provoking regarding our ownmanage-
ment strategies.
First, it appears that your center has been fairly aggressive at in-
tervening for even mild to moderate AV regurgitation at an early
age. We have found significant improvement in the degree of AV
regurgitation with the volume unloading effects of the second-
stage cavopulmonary connection, and therefore we have not
been intervening for moderate or less AV regurgitation at that
stage. Looking at the relatively small percentage of patients within
your study who did have AV repair, how is the decision made to
intervene for some of the patients with only mild to moderate re-
gurgitation and not others? And do you know the natural history
of those patients who do not have intervention, perhaps through
your case–control study?
Dr Honjo. That’s a very good point. Our strategy is to take
a look at the AVat stage II palliation if patient has a mild to mod-
erate regurgitation, regardless of the mechanism of regurgitation.
Our study shows that the vast majority of patients actually have
anatomic abnormality, rather than just functional regurgitation.
So it’s worth to taking a look at the AV. If there is anatomic issue
detected, we can adequately fix it.
We didn’t have enough patients with mild to moderate or mod-
erate regurgitation who didn’t undergo an AV repair to conduct
a good matching study to compare or look at the natural history
of unrepaired patient outcome. There is a study from Philadelphia
showing that patients with mild to moderate regurgitation, or even
moderate regurgitation, who did not have repair at the stage IIery c August 2011
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study also suggested, however, that some of these patients required
the valve repair at the Fontan operation. We believe that the pres-
ervation of ventricle geometry and function is crucial, so our con-
sistent strategy is to intervene in cases of borderline mild to
moderate regurgitation at the stage II palliation.
Dr Hirsch. Second, given the high prevalence of single right
ventricle and primary tricuspid valve morphologies, do you be-
lieve that the development of significant AV regurgitation is a result
of the morphologically right ventricle being incapable of function-
ing as well under systemic pressures? If so, should these patients
be managed differently from a medical standpoint, such as more
aggressive afterload reduction to mitigate this risk and stabilize
the annulus?
Dr Honjo. I think that’s a good point. In our patient group, more
than 80%of the patients havemorphologically right ventriclewith ei-
ther anatomic tricuspid valve or commonAV. If they start to have AV
regurgitation or progressive ventricular dilatation, they need aggres-
sivemedical therapy to reduce afterload.We believe that to intervene
for those patients at stage II is part of an overall strategy that willmin-
imize irreversible changes in ventricular function and geometry.
Dr Hirsch. Given the variable approaches to annuloplasty and
partial annuloplasty in this patient population that have been re-
ported, do you use a standard technique for your annuloplasty?
If so, what is that technique?
Dr Honjo.We used very standard techniques. We only use the
ring annuloplasty or circumferential annuloplasty when the annu-
lus is at or near adult size. More than 95% of the patients actually
have localized annuloplasty where the leak originates. We also
combine either anatomic functional commissuroplasty at the loca-
tion of the regurgitation. Some patients underwent edge-to-edge
type repairs, especially the patient with common AV.
DrHirsch.Do you think that with the coming availability of the
bioabsorbable ring that perhaps you’ll use that more frequently in
this patient population to further stabilize the annulus?
Dr Honjo. You mean the artificial ring?
Dr Hirsch. Bioabsorbable.
Dr Honjo. I’m not sure.
Dr Hirsch. It’s not yet commercially available. I’m thinking in
the future of new technologies that may benefit these patients.
Dr Honjo. Right. That might be a good idea.
Dr Hirsch. Finally, given the increased risk of failure in your
patients with poor ventricular function and significant annular
dilatation, do you believe that early listing for transplant may be
appropriate for this patient population?The Journal of Thoracic and CaDr Honjo. That’s a good point. I think that we have to consider
transplant early when we have a patient who has reduced ventric-
ular function after AV repair. Those are the patients who are at
really high risk of death or transplant anyway. The issue is that
we cannot predict who is going to have postrepair severe ventric-
ular dysfunction according to the preoperative values in our study.
That’s one thing we have to sort out in a future study.
Dr Hirsch. Again, congratulations on an outstanding presenta-
tion and exemplary results in a very difficult patient population.
Dr Honjo. Thank you very much.
Dr Peter B. Manning (Cincinnati, Ohio).You said that most of
your valves were anatomically abnormal and that most of your pa-
tients had hypoplastic left heart syndrome, and I don’t think we
usually think of patients with hypoplastic left heart syndrome as
having anatomically abnormal tricuspid valves. Are you basing
the characterization of abnormal on the fact that you had a high
percentage of annular dilatation and prolapse according to echo-
cardiography? Annular dilatation with reference to what normal
value? I’m guessing there probably aren’t normal values for sin-
gle-ventricle annular dimensions. With your case–control study,
you might have a comparison group to justify that.
I also worry that prolapse may also be a function more of ven-
tricular dysfunction than of actual anatomic findings. So were the
surgical intraoperative findings consistent with what you’re char-
acterizing as echocardiographic anatomic abnormalities? That is
my first question.
DrHonjo. That’s a very good point.We actually are performing
an ongoing study correlating the surgical and echocardiographic
findings in this study. We do, however, have a fair correlation be-
tween the evaluation of the echocardiograms that were done in this
study and actual surgical findings. The pathologic study also
showed that more than a third of the patients with hypoplastic
left heart syndrome actually had anatomic abnormality, mainly
dysplasia, so it’s not surprising that the vast majority of patients
in this patient group had anatomic abnormalities.
Dr Manning. I think that the whole problem is a difficult
chicken-and-egg situation sometimes. Is the valve regurgitation
the problem, or is it the ventricular dysfunction that’s the primary
problem? Perhaps, particularly with some of these patients, what
you’re showing is there is a significant red flag. and you can repair
the valve all you want but the ventricle is still the problem and
that’s failing.
I think this is very useful information, and further long-term
follow-up looking at trying to get these kids out to 20 and 30 years
is really what we’re all striving for.rdiovascular Surgery c Volume 142, Number 2 335
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FIGUREE1. Changes in atrioventricular valve regurgitation grade before
and after atrioventricular valve repair. The regurgitation grade was signif-
icantly reduced by the atrioventricular valve repair. Three of the 13 patients
with severe atrioventricular valve insufficiency (23%) and 4 of the 38
patients with moderate atrioventricular valve insufficiency (10%) had
moderate residual atrioventricular valve insufficiency (12% of the entire
cohort). All the patients with mild to moderate regurgitation showed
improvement to mild or trivial regurgitation.
TABLE E1. Preoperative profile
No. of patients 57
Age (mo, median and range) 6.8 (0.3–209)
Body weight (kg, median and range) 6.95 (2.1–58.8)
Male/female ratio 32:26
Diagnosis (no.)
Hypoplastic left heart syndrome 32 (59%)
Double-outlet right ventricle 8 (15%)
Atrioventricular septal defect 10 (19%)
Tricuspid atresia and double-inlet left ventricle 4 (7%)
Isomerism 5 (9%)
Ventricular morphology (no.)
Right ventricle 48 (83%)
Left ventricle 8 (13%)
Indeterminate 2 (4%)
Timing of valve repair (no.)
Stage I (Norwood) 2 (3%)
Stage II (bidirectional cavopulmonary shunt) 33 (59%)
Between stage II and III 10 (17%)
Stage III (Fontan) 10 (17%)
After stage III 2 (3%)
TABLE E2. Grading of atrioventricular valve insufficiency, stenosis,
and ventricular function, and subgroups according to postrepair
atrioventricular valve and ventricular function
Grade or group Description
Atrioventricular valve insufficiency
0 None or trivial
1 Mild
2 Moderate
3 Severe
Atrioventricular valve stenosis
0 No inflow pressure gradient
1 Mild (mean pressure gradient<5 mm Hg)
2 Moderate (mean pressure gradient 5–10 mm Hg)
3 Severe (mean pressure gradient>10 mm Hg)
Ventricular function
0 Normal
1 Mildly reduced
2 Moderately reduced
3 Severely reduced
Subgroup
Group 1 Successful repair (no more than mild to
moderate regurgitation) with normal
ventricular function
Group 2 Poor repair (at least moderate regurgitation)
with normal ventricular function
Group 3 Successful repair with poor ventricular
function (at least moderately reduced)
Group 4 Poor repair with poor ventricular function
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TABLE E3. Repair techniques, operative variables, and postrepair
echocardiographic findings
Variables
Operative techniques (no.)
Annuloplasty 46 (85%)
Commissuroplasty 29 (54%)
Valvuloplasty 12 (22%)
Chordal repair 2 (4%)
Cleft closure 18 (33%)
Edge-to-edge repair 17 (29%)
Papillary muscle repair 1 (2%)
Operative variables
Cardiopulmonary bypass (min, median and range) 118 (50–405)
Crossclamp (min, median and range) 60 (15–178)
Circulatory arrest (no.) 15 (25%)
Circulatory arrest time (min, median and range) 22 (2-67)
Residual atrioventricular valve insufficiency (no.)
None or trivial 14 (26%)
Mild 33 (61%)
Moderate 7 (13%)
Postrepair atrioventricular valve stenosis (no.)
None or trivial 45 (83%)
Mild 8 (15%)
Moderate 1 (2%)
Postrepair ventricular function
Normal 36 (63%)
Mildly reduced 10 (17%)
Moderately reduced 7 (13%)
Severely reduced 4 (7%)
TABLE E4. Causes of early and late deaths
Cause of death No.
All-cause in-hospital deaths 8
Moderate residual atrioventricular valve insufficiency
Sudden arrest 1
Progressive ventricular failure 1
Poor myocardial protection 1
Hypoplastic left heart syndrome after Norwood procedure
Cardiac arrest 2
Hypoxia, sepsis, supraventricular tachycardia after
second valve repair
1
Superior vena cava thrombosis 1
Fontan takedown, low cardiac output 1
All-cause late deaths 9
Mechanical valve replacement related
Stuck valve after atrioventricular valve
replacement, ventricular dysfunction
1
Gastrointestinal bleeding on postoperative
extracorporeal membrane oxygenation after
atrioventricular valve replacement
1
After heart transplant
Acute rejection 1
Respiratory arrest 1
Failed Fontan, cardiac arrest 1
Sudden death at home 1
Multiple venous thrombosis 1
Pneumonia, sepsis 1
Pulmonary hypertension, pulmonary vein stenosis, infection 1
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